Clinical Trial 8114

San Antonio, TX 78258

Study Summary:

Phase III randomized double blind placebo controlled multi-center study to evaluate the safety and efficacy of Dutogliptin in patients with Type II Diabetes on background treatment with or without Metformin.

Qualified Participants Must:

• Be newly diagnosed with Type II Diabetes or taking Metformin
• Be 18 - 85 years of age
• Have BMI between 20 - 48

Qualified Participants May Receive:

Glimepiride study ip, physical exam, lab work, ECGs, glucometers with supplies at no cost, compensation for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.